MESQUITE, NV / ACCESSWIRE / September 24, 2019 / Cannabis Sativa, Inc. (OTCQB: CBDS) announces the offering for sale of CBDs.com, a premier domain name, for $2,500,000. “We believe that CBDs.com is the best CBD domain name available and that it has a premium value to the right buyer”, stated CEO David Tobias. “CBDoil.com sold recently for $500,000, and a four-letter domain with the search engine optimization capacity of CBDs.com is certainly more desirable”. Interested parties may contact Cannabis Sativa, Inc. for more information. “With the current competitive positioning, branding and marketing campaigns of CBD companies, we feel it’s the perfect time to test the marketability of CBDs.com. We are very pleased with the recent acquisition of CannabisSativa.com and intend for it to become the ultimate complement to our corporate identity, even more so than the reflection of our ticker symbol CBDS in the domain CBDs.com”, Tobias concluded.
About Cannabis Sativa, Inc.:
Cannabis Sativa, Inc. (“CBDS”) is engaged in the licensing of cannabis related intellectual property, marketing and branding for cannabis based products and services, operation of cannabis related technology services, and ancillary business activities. CBDS licenses the “hi” and “White Rabbit” brands, holds a U.S. patent on the Ecuadorian Sativa strain of Cannabis, a U.S. Patent for a marijuana lozenge; a Cannabis-based pharmaceutical composition for the treatment of hypertensive disorders by submucosal delivery and trade secret formulas and processes, and operates subsidiaries including: PrestoDoctor® (https://prestodoctor.com), Wild Earth Naturals® (https://wildearthnaturals.com), and iBudtender (https://ibudtender.com). The Company is the official licensee for Virgin Mary Jane Brand (https://virginmaryjanebrand.com). In addition, CBDS seeks strategic partners for acquisition of operating companies, intellectual property and other assets which fit within the CBDS corporate vision.
This press release contains “forward-looking statements.” Although the forward-looking statements in this release reflect the good faith judgment of management, forward-looking statements are inherently subject to known and unknown risks and uncertainties that may cause actual results to be materially different from those discussed in these forward-looking statements. Readers are urged to carefully review and consider the various disclosures made by us in our reports filed with the Securities and Exchange Commission, including the risk factors that attempt to advise interested parties of the risks that may affect our business, financial condition, results of operation and cash flows. If one or more of these risks or uncertainties materialize, or if the underlying assumptions prove incorrect, our actual results may vary materially from those expected or projected. Underlying assumptions include without limitation, the ongoing enactment of legislation favorable to the production of and the commercialization of cannabis products and the Company’s success in capitalizing on that legislation. Readers are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. We assume no obligation to update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this release.
Corporate (702) 346-3906
Mesquite, NV 89027
SOURCE: Cannabis Sativa, Inc.
View source version on accesswire.com: